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This study demonstrates that in mice subjected to hypoxia-ischemia (HI) brain injury isoflur-
ane anesthesia initiated upon reperfusion limits a release of mitochondrial oxidative radicals
by inhibiting a recovery of complex-I dependent mitochondrial respiration. This significantly
attenuates an oxidative stress and reduces the extent of HI brain injury. Neonatal mice were
subjected to HI, and at the initiation of reperfusion were exposed to isoflurane with or with-
out mechanical ventilation. At the end of HI and isoflurane exposure cerebral mitochondrial
respiration, H2O2 emission rates were measured followed by an assessment of cerebral oxi-
dative damage and infarct volumes. At 8 weeks after HI navigational memory and brain atro-
phy were assessed. In vitro, direct effect of isoflurane on mitochondrial H2O2 emission was
compared to that of complex-I inhibitor, rotenone. Compared to controls, 15 minutes of iso-
flurane anesthesia inhibited recovery of the compex I-dependent mitochondrial respiration
and decreased H2O2 production in mitochondria supported with succinate. This was associ-
ated with reduced oxidative brain injury, superior navigational memory and decreased cere-
bral atrophy compared to the vehicle-treated HI-mice. Extended isoflurane anesthesia was
associated with sluggish recovery of cerebral blood flow (CBF) and the neuroprotection was
lost. However, when isoflurane anesthesia was supported with mechanical ventilation the
CBF recovery improved, the event associated with further reduction of infarct volume com-
pared to HI-mice exposed to isoflurane without respiratory support. Thus, in neonatal mice
brief isoflurane anesthesia initiated at the onset of reperfusion limits mitochondrial release
of oxidative radicals and attenuates an oxidative stress. This novel mechanism contributes
to neuroprotective action of isoflurane. The use of mechanical ventilation during isoflurane
anesthesia counterbalances negative effect of isoflurane anesthesia on recovery of cere-
bral circulation which potentiates protection against reperfusion injury.
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Introduction
Neonatal hypoxia-ischemia (HI) brain injury remains one of the major causes of life-long neu-
rological morbidity. Although, permanent brain injury occurs due to severe oxygen and nutri-
ent deprivation, the mechanisms of post-ischemic damage are initiated by reperfusion.
Oxidative stress is one of these mechanisms where mitochondria play a central role in genera-
tion of injurious reactive oxygen species (ROS). Upon reintroduction to oxygen mitochondria
quickly reactivate electron transport in their respiratory chains [1], an event vital for cellular
survival. However, the same process accelerates a release of deleterious ROS from mitochon-
dria [2]. Our group and others have shown that inhibition of complex-I (C-I) during ischemia
and/or reperfusion significantly reduced the extent of ischemic damage to the developing and
mature brains and hearts. This was associated with attenuation of oxidative stress [3–5]. How-
ever, agents (pyridaben or rotenone) used for inhibition of C-I in experimental ischemia-reper-
fusion injury are not translatable for clinical practice.
Isoflurane anesthesia used as pre-or post-treatment protects immature brains against HI-in-
jury [6–9]. Because isoflurane inhibits C-I activity [10, 11], and similarly to a C-I inhibitor, ro-
tenone, reduces ROS generation in mitochondria supported with succinate [11], we
hypothesized that these metabolic effects of isoflurane contribute to neuroprotective mecha-
nisms of post-conditioning with isoflurane anesthesia. Almost immediate on/off pharmacolog-
ical action makes isoflurane an excellent drug of choice for reversible inhibition of C-I recovery
in reperfusion in order to reduce a reperfusion-driven surge in ROS production from mito-
chondria. This study was undertaken to determine whether in the neonatal mouse model of
HI-brain injury isoflurane anesthesia initiated at the onset of reperfusion attenuates oxidative
damage to HI-brain by inhibition of mitochondrial ROS generation surge.
Materials and Methods
The model of unilateral HI brain injury and study groups
All studies were approved by the Columbia University Institutional Animal use Committee ac-
cording to AAALAC standards. We used the Rice-Vannucci model of regional HI-brain injury
in rats [12], adapted to p10 C57Bl6/J neonatal mice [3, 13]. The model consisted of a ligation of
the right common carotid artery followed by recovery for 1.5 h and hypoxic (8% O2 balanced
N2) exposure for 15 minutes at the ambient temperature 37.0–37.5°C, as we described [3, 13].
Following hypoxic exposure one group of HI-mice was re-oxygenated with room air (RA)—
HI-control. Other three groups of mice were re-oxygenated with 0.9 MAC (2.0 Vol%) isoflur-
ane for either 15 or 30 minutes of initial reperfusion, or for 15 minutes starting at 30 minutes
of reperfusion (Fig. 1A). Isoflurane exposure was supplemented with 30% oxygen in order to
maintain systemic SaO2 at physiological range 90% (Fig. 1B). The dose of isoflurane (0.9
MAC or 2 Vol%) for p10 C57Bl6/J mice was selected according to the report [14]. In this report
authors concluded that similar to human neonates, isoflurane anesthesia in neonatal mice
should be combined with mechanical ventilation (MV). Therefore, a separate cohort of mice
was exposed to post-HI 0.9 MAC isoflurane anesthesia combined with MV. In this experiment
MV was performed as we described [15] with minor modifications. In brief, immediately fol-
lowing HI-insult mice were exposed to isoflurane, their trachea was intubated with angiocath
24G and mice were placed on the respirator MicroVent 848 (Harvard Apparatus). The tidal
volume was 6 μl/g of body weight. The respiration rate was kept at 110 breath/minute to main-
tain paCO2 within physiological range. The duration of isoflurane exposure was 15 or 30 min-
utes of initial reperfusion (Fig. 1A). Once isoflurane exposure was discontinued, mice were
extubated and returned to their dams. To determine the extent of brain injury in spontaneously
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Fig 1. Experimental design. Mitochondrial phosphorylating respiration rates after HI. (A)—HI-mice, upon reperfusion, were exposed to either room air
or isoflurane with or without mechanical ventilation (MV) for different time of reperfusion. (B)—Changes in SaO2 in naive mice (n = 6), and mice exposed to 2
Vol% isoflurane with (n = 6) or without (n = 4) 30% oxygen supplementation, * p< 0.01. (C)—Mitochondrial phosphorylating and uncoupled respiration rates
in naïve mice (n = 10), HI-mice at the end of HI-insult (n = 5), and at 15 minutes of reperfusion under isoflurane (HI+Iso, n = 14) or without (HI+RA, n = 14)
isoflurane anesthesia. (D)—Representative cerebral mitochondrial respiration tracings from HI-mice tested at the end of HI (End of HI) and 15 minutes of
reperfusion with isoflurane exposure (15’Rep+Iso) or room air (15’ Rep+RA).
doi:10.1371/journal.pone.0120456.g001
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respiring animals, 136 mice were used, and 44 mechanically-ventilated mice were used. For a
long-term neurological assessment 49 mice were used. These mice were sacrificed by cervical
dislocation under isoflurane anesthesia at 24 hours following HI-insult. In addition, 90 neona-
tal mice were used for mitochondrial and oxidative brain damage assay. These mice were sacri-
ficed at 0 and 15 minutes and 24 hours of reperfusion by cervical dislocation.
The measurement of SaO2, cerebral blood flow and blood gases
Systemic saturation of the circulating arterialized hemoglobin with oxygen (SaO2) was mea-
sured in a separate cohort of naïve p10 mice subjected to 0.9 MAC isoflurane with or without
oxygen supplementation and compared to naïve animals kept in room air. To measure SaO2, a
pulseoxymetry probe was placed around the neck and SaO2 values were constantly recorded up
to 30 minutes using mouse pulseoximeter (Starr Life Sciences, Pittsburgh, PA). In randomly se-
lected HI-animals changes in cerebral blood flow (CBF) in response to HI and re-oxygenation
with or without 0.9 MAC isoflurane and ventilation were measured using laser Doppler flow-
meter “Periflux 5000”, as we described [1, 16]. Briefly, under isoflurane anesthesia a laser-
Doppler probe was attached to the ipsilateral hemisphere skull using 15 cm long fiberoptic ex-
tension. Fiberoptic extension was placed 3 mm lateral to and 2 mm posterior to the bregma.
CBF value was expressed as % of the initial pre-hypoxic level. In a separate group of naïve p10
mice exposed to 0.9 MAC isoflurane for 15 minutes with or without MV blood gases analysis
was performed using EPOC analyzer (Epocal, Alere Inc.) in samples obtained from the right
common carotid artery.
Short- and long-term assessment of the HI-brain injury
At 24 hours of reperfusion mice were sacrificed, brains were harvested, sectioned into 1 mm
thick coronal slices and stained with 2% triphenyl-tetrazolium chloride (TTC). Digital images
of infracted and viable areas of brains were traced (Adobe Photoshop 4.0.1) and analyzed (NIH
image 1.62J) by the investigator (S.S.) “blinded” to a study groups. The extent of brain injury
was expressed as a percentage of the hemisphere ipsilateral to the carotid artery ligation side.
A long-term neurological assessment was performed at 8 weeks after HI by evaluation of
navigational memory in the Morris water maze. The test was carried out as we described [13],
with minor modifications. For three consecutive days (three trials a day) mice were trained to
find a submerged platform in the pool Ø110 cm. On the day four, mice were offered a probe
trial, when a platform was removed and time spent in the “platform” quadrant was recorded.
The allotted time on probe trial was 60 seconds. At the completion of navigational memory
evaluation mice were euthanized. Brains were removed and fixed in 4% paraformaldehyde.
Coronal sections (40 μm thick every 500 μm) were Nissl stained. Digital images were obtained
and processed as described above. The extent of cerebral atrophy in the ipsilateral hemisphere
was defined as percentage in relation to corresponding contralateral hemisphere (100%).
Assessment of mitochondrial function
At 0 and 15 minutes of reperfusion cerebral non-synaptic mitochondria were isolated from the
ipsilateral hemisphere as we described [3, 17]. In brief, brain hemisphere was harvested and im-
mediately immersed into 2 ml of ice-cold isolation buffer. The tissue was homogenized manu-
ally using a dounce homogenizer (Wheaton Ind., NJ) with 0.2 mm differential (10 strokes) and
followed by 0.1 mm differential (10 strokes). The homogenate was centrifuged at 1100 g for
2 min in a refrigerated (+4°C) table-top centrifuge (Eppendorf 5810R). The pellets were dis-
carded and the 0.750 ml of supernatant was mixed with 0.07 ml of 80 vol% Percoll solution,
carefully layered on top of 0.7 ml of 10% Percoll solution and centrifuged at 18,500 g for
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10 min. The mitochondria—enriched fraction was collected at the bottom of the tube and re-
suspended in 1.0 ml of sucrose washing buffer. The suspension was centrifuged at 10,000 g for
5 min. The final mitochondrial pellet was re-suspended in 0.07 ml of albumin-free washing
buffer, and stored on ice. Using NAD or FAD-linked substrates, malate-glutamate or succinate,
respectively, mitochondrial respiration and H2O2 emission rates were measured. To assess di-
rect effect of isoflurane on mitochondrial H2O2 generation rate, cerebral mitochondria isolated
from naïve p10 mice were exposed to the buffer pre-bubbled (60 seconds) with either RA (nor-
moxia), or 100% O2 with or without 2 Vol% isoflurane. In vitro hyperoxia imitates a post-is-
chemic re-oxygenation. Rotenone (stock 0.5 mM in 96% alcohol, 2 μl / 1000 μl buffer) was
used as a control for inhibition of C-I. Alcohol (96%, 2 μl / 1000 μl buffer) was used as
a vehicle.
Mitochondrial respiration was measured using a Clark-type electrode (Oxytherm, Hansa-
tech, UK), as we described [1, 13, 16]. Briefly, mitochondria (0.05 mg of protein) were added to
0.5 ml of respiration buffer: 10 mMMOPS-Tris, pH 7.4, 120 mM KCl, KH2PO4 1 mM, EGTA
10 μM, 0.2 mg/ml of BSA, 30 μMAp5A (P
1,P5-di(adenosine 5')-pentaphosphate), 10 mM glu-
tamate, and 5 mMmalate at t = 32°C. Phosphorylating respiration was initiated with 100 nmol
of ADP and uncoupled respiration was initiated by adding 40μM of 2’3 dinitrophenol (DNP).
Mitochondrial H2O2 emission was estimated by Amplex ultrared fluorescence assay using
Hitachi 7000 spectrofluorimeter set at 555 nm excitation and 581 nm emission as described
earlier [3, 18]. Briefly, mitochondria (0.05 mg/ml) were placed in 1 ml of respiratory buffer
containing 5 mM succinate or 5mMmalate/10 mM glutamate, 10 μM amplex ultrared and
4 U/ml of horse radish peroxidase (HRP) and the rate of H2O2 fluorescence raise was recorded.
At the end of each experiment five aliquots of 100 nmol of H2O2 was added to the respiration
buffer every 60 sec to obtain a calibration curve. The rates of H2O2 emission were expressed in
pmolH2O2/mg of protein/min.
Assessment of oxidative injury to the brain tissue and mitochondria
Oxidative damage to mitochondria (decreased aconitase activity) was assessed as we described
[3]. Frozen-thawed mitochondria were mixed with the reaction buffer (50 mmol/L Tris-HCl,
pH 7.4, 0.6mmol/L MnSO4, 5mmol/L Na citrate, 0.5 mmol/L nicotinamide adenine dinucleo-
tide phosphate (NADP), 1 U/mL iso-citrate dehydrogenase) in a 96-well plate and the absor-
bance changes at 340nm were followed for 10 minutes with a plate reader (Tecan Infinite
M200, San Jose, CA, USA). The aconitase activity was expressed in mU per minute per mg of
mitochondrial protein. Aconitase activity was expressed in mU/min/mg of mitochondrial pro-
tein. Oxidative proteins damage in the brain was evaluated by detection of 3-nitrotyrosine
(3-NT) using western blot (anti-3NT, 1:1000; Millipore).
Statistical analysis
One-way ANOVA with Fisher’s post-hoc analysis was used to detect statistical differences in
brain infarct volumes, navigational memory and mitochondrial functions. Changes in CBF and
SaO2 were analyzed using ANOVA for repeated measures with Fisher’s post-hoc analysis. T-
test was used to detect differences in the brain infarct volume between HI-mice exposed to iso-
flurane with or without mechanical ventilation. All data are mean ± SEM. Difference was con-
sidered statistically significant if p-value< 0.05.
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Results
Post-HI isoflurane anesthesia inhibits recovery of C-I dependent
respiration and the reperfusion-driven acceleration in mitochondrial ROS
release
Compared to mitochondria isolated from naïve mice, mitochondria isolated from the hypoxic-
ischemic hemisphere at the end of HI-insult, before isoflurane exposure, exhibited significant
depression of C-I dependent phosphorylating and DNP-accelerated respirations (Fig. 1C and
D). At 15 minutes of reperfusion in mice reoxygenated with RA mitochondrial respiration re-
covered compared to that measured at the end of HI. In contrast, in mice reoxygenated under
isoflurane anesthesia, cerebral mitochondria continued to exhibit depressed C-I dependent
state 3 and uncoupled respirations (Fig. 1C and D). When the same mitochondria from the
mice reoxygenated with RA were fueled with C-II dependent substrate, succinate, we found a
brisk acceleration of H2O2 emission compared to that measured at the end of HI (Fig. 2A).
However, exposure to isoflurane significantly attenuated this acceleration of succinate-sup-
ported H2O2 emission from post-HI mitochondria (Fig. 2A).
Isoflurane inhibits mitochondrial H2O2 emission surge induced by
hyperoxia
These in vitro experiments imitate a surge in mitochondrial ROS production initiated by the
reintroduction of O2 into ischemic brain. In response to increase in oxygen content cerebral
mitochondria fueled with succinate exhibited a dramatic (p< 0.0001) acceleration of the H2O2
emission rate compared to normoxia (Fig. 2B). However, in the presence of isoflurane, this
hyperoxia-induced surge in mitochondrial H2O2 production was significantly blunted
(Fig. 2B). Similar effect was achieved by an inhibition of C-I with rotenone (Fig. 2B). When the
same organelles were supported with malate-glutamate, the baseline H2O2 emission rate was
very low,* 30 folds slower compared to the succinate-fueled H2O2 production. Hyperoxia sig-
nificantly increased ROS emission rate (Fig. 2C), especially in the presence of rotenone and to
a lesser extent, in the presence of isoflurane (Fig. 2C).
Post-HI isoflurane anesthesia is associated with reduced oxidative injury
Compared to naïves, the aconitase activity, a marker of oxidative damage to the mitochondrial
matrix, was significantly decreased in HI-mice reoxygenated with RA or isoflurane (Fig. 3 A).
However, compared to RA-reoxygenated HI-mice, HI-mice exposed to isoflurane exhibited
significantly greater preserved aconitase activity (Fig. 3 A). A marker of protein oxidative dam-
age, 3NT, was significantly increased following HI-insult (Fig. 3 B and C). In the HI-mice treat-
ed with isoflurane, 3NT-level was significantly lower compared to the RA-treated HI-mice
(Fig. 3 B and C).
Only brief isoflurane anesthesia initiated after HI is neuroprotective
At 24 hours of reperfusion HI-mice exposed to isoflurane for initial 15 minutes of reperfusion
demonstrated significantly decreased cerebral infarct volume compared to their RA reoxygen-
ated controls (Fig. 3D). However, when the same isoflurane exposure was delayed and was ini-
tiated at 30 minutes of reperfusion no neuroprotection was observed (Fig. 3D). Surprisingly, an
extension of post-HI isoflurane anesthesia to 30 minutes of initial reperfusion also did not af-
fect the extent of brain injury compared to RA reoxygenated controls (Fig. 3D). In these mice
the infarct volume was significantly greater compared to that in HI-mice post-treated with the
same regimen of isoflurane for 15 minutes (Fig. 3D). Thus, the neuroprotection was detected
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Fig 2. In-vitro and ex-vivo effect of isoflurane onmitochondrial ROS release. (A)—Mitochondrial H2O2 emission rate and representative H2O2
fluorescence tracings in HI-mice at the end of HI (n = 6) and at 15 minutes of reperfusion with (n = 6) or without (n = 6) isoflurane anesthesia. (B and C)—
H2O2 emission rates with representative H2O2 fluorescence tracings frommitochondria fueled with succinate (B) or malate-glutamate (C) and exposed to
hyperoxic buffer (O2) in the presence of vehicle (O2 + Veh, n = 4 and 6), or Isoflurane (O2 + Iso, n = 4 and 6), or Rotenone (O2 + Rot, n = 4 and 6) and
compared to controls (Normox, n = 4 and 6). P-values and study groups are indicated. * p< 0.01 compared to normoxia.
doi:10.1371/journal.pone.0120456.g002
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Fig 3. Post-HI isoflurane anesthesia attenuates oxidative brain damage and extent of brain injury. (A and B)—Mitochondrial aconitase activity and
expression of 3-Nitrotyrosine in brains obtained from naïve mice (n = 11 and 7) and in HI-mice reperfused for initial 15 minutes with isoflurane (n = 12 and 9)
or RA (n = 10 and 6). (C)—representative 3-Nitrotyrosine western blot. (D)—Infarct volume and representative TTC-stained cerebral images of HI-mice
reperfused without (RA, n = 50), or with isoflurane anesthesia: for initial 15 min (n = 35), or initial 30 min (n = 35), or delayed (30–45 minutes, n = 16).
doi:10.1371/journal.pone.0120456.g003
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only in the HI-mice post-treated with isoflurane for initial 15 minutes. Therefore, this group of
mice was studied for a long-term neurological outcome. At 10 weeks of life these mice exhib-
ited significantly better navigational memory and significantly better-preserved ipsilateral
hemisphere compared to their RA-reoxygenated controls (Fig. 4A, B).
Isoflurane anesthesia alters post-HI recovery of the cerebral blood flow
in spontaneously breathing mice
Compared to the control HI-mice, their littermates anesthetized with isoflurane without MV
exhibited significantly poorer recovery of the CBF (Fig. 5A). In mice exposed to isoflurane for
15 minutes a brisk CBF recovery was detected only when anesthesia has been discontinued
Fig 4. Long-term neurological outcome of the HI-brain injury after isoflurane exposure. (A)—Navigational memory: time spent in the “platform
quadrant” by naïve mice (n = 21) and HI-mice re-oxygenated without (HI, n = 14), or with isoflurane (HI+Iso, n = 14). Representative tracings of swimming
path during probe trial in the same groups of mice. (B)—Extent of brain atrophy in the ipsilateral hemisphere and representative Nissl-stained brain images
from adult mice treated with isoflurane for initial 15 minutes of reperfusion (HI+Iso, n = 13) or RA (HI, n = 14).
doi:10.1371/journal.pone.0120456.g004
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Fig 5. Mechanical ventilation enhances neuroprotection of isoflurane. (A)—CBF during HI and
reperfusion in mice re-oxygenated with RA (n = 4) or Isoflurane for initial 15 minutes (Iso—RA, n = 4), or 30
minutes (Iso, n = 4), or mice re-oxygenated with isoflurane combined with mechanical ventilation (Iso+Vent,
n = 4). * p< 0.02 between groups, Dashed square indicates analyzed area. (B)—Infarct volume in mice re-
Isoflurane, Mitochondria and Hypoxia-Ischemia
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(Fig. 5A). If isoflurane anesthesia was extended, the CBF remained depressed (Fig. 5A). Com-
pared to naïve animals, isoflurane exposure in spontaneously breathing mice significantly in-
creased paCO2 (Table 1). The use of MV during isoflurane anesthesia normalized paCO2,
HCO3
− and significantly improved CBF recovery (Fig. 5A).
Mechanical ventilation during post-HI isoflurane anesthesia enhances
neuroprotective action of isoflurane
Because in spontaneously breathing HI-mice isoflurane anesthesia depressed cerebral reperfu-
sion, we reasoned that this sluggish CBF recovery counterbalances beneficial metabolic effect
of isoflurane. Indeed, compared to spontaneously respiring HI-mice, the exposure to isoflurane
with MV significantly greater reduced infarct volume (Fig. 5B). The use of MV with 30 minutes
of isoflurane anesthesia also significantly decreased the extent of brain damage compared to
that in spontaneously breathing counterparts (Fig. 5B). However, no neuroprotection was
achieved compared to the vehicle-treated HI-mice (mean ± SE infarct volumes: vehi-
cle = 39.7 ± 2.78 vs Isoflurane = 30.4 ± 5.07, p = 0.08).
Discussion
This report is the first to demonstrate that in neonatal HI-mice, post-conditioning with isoflur-
ane anesthesia, initiated at the onset of reperfusion, inhibited recovery of C-I dependent mito-
chondrial respiration and significantly reduced a reperfusion-driven surge in generation of
mitochondrial ROS. This significantly reduced an oxidative injury to the HI-brain, the event
associated with permanent neuroprotection.
Post-ischemic mitochondria are one of the major sources of oxidative radicals released dur-
ing reperfusion. The mechanism of ROS generation in mitochondrial respiratory chain de-
pends on mitochondrial substrate which defines directions of electron transport flow, affecting
sites and rates of ROS generation. In organelles fuelled with succinate, a reverse electron trans-
port (RET) flow (electron flux proceeds backward from C-II, ubiquinone to C-I and to the ma-
trix-located NAD) serves as a primary mechanism for generation of ROS. The main site of
ROS production in RET flow is C-I [19]. Here and in other studies we have found a brisk accel-
eration of ROS production in response to reperfusion in mitochondria fueled with succinate
(Fig. 2A) [3]. This has been attributed to a rapid recovery of RET-flow in C-I. Because C-I inhi-
bition, for example with rotenone, interrupts RET-flow and dramatically decreases ROS emis-
sion [2, 18], it has been proposed that an inhibition of C-I dependent recovery of RET-flow
reduces formation of ROS in the post-ischemic brain and heart [3, 20]. Our study demonstrates
that in vitro effect of isoflurane on RET and FET flows-dependent mitochondrial H2O2
oxygenated under isoflurane anesthesia for 15 or 30 minutes with (n = 22) or without (n = 35) mechanical
ventilation. * p = 0.017 compared to the mice ventilated for 30 minutes.
doi:10.1371/journal.pone.0120456.g005
Table 1. Blood gases during isoflurane anesthesia with or without MV.
Mice pH paCO2 HCO3-
Naïve n = 5 7.41 ± 0.025 38.6 ± 3.5 24.6 ± 0.98
Iso. n = 4 7.25 ± 0.031 69.0 ± 5.03* 30.7 ± 0.39*
Iso. MV n = 4 7.33 ± 0.01 44.0 ± 4.00 23.2 ± 1.7
* p < 0.002 compared to Iso. MV group. Data are Mean ± SEM
doi:10.1371/journal.pone.0120456.t001
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generation fully simulated the action of C-I inhibitor, rotenone. Therefore, we propose that in
our vivo experiment isoflurane limits RET-driven mitochondrial ROS generation upon reper-
fusion. Similar results were obtained in isolated heart ischemia-reperfusion injury pre-exposed
to isoflurane [20]. Our study supports a pathogenic role of the ROS originating in C-I during
RET-flow by demonstrating a novel action of isoflurane anesthesia; attenuation of oxidative in-
jury secondary to inhibition of the recovery of C-I. Thus, in the post-HI brain isoflurane inhib-
its reactivation of C-I which limits a surge of ROS release during restoration of RET-flow in
reperfusion. This data-interpretation agrees with report showing reduced accumulation of hy-
droxyl radicals and products of lipid peroxidation achieved by an inhibition of C-I with rote-
none or haloperidol in rats with cerebral ischemia [4]. Inhibition of C-I with amytal also
reduced level of free radicals and lipid peroxidation in isolated rabbit and rat hearts subjected
to ischemia-reperfusion [5, 21], and similar effect of isoflurane on isolated cardiac mitochon-
dria has been reported [22].
Our data on mitochondrial ROS emission were obtained using ex-vivo isolated organelles
fuelled with succinate. The rationale for the use of succinate rests on a body of evidence sug-
gesting, that succinate serves as a primary mitochondrial substrate at the onset and early reper-
fusion in the ischemic hearts [23, 24] and brains [25, 26]. In the rat brain, ischemia profoundly
depleted all NAD-linked substrates, but concentration of succinate was increased by* 300%
[25], and remained elevated for 15 minutes of reperfusion [25, 26]. In neonatal asphyxiated
piglets concentration of circulating succinate in reperfusion reached 8000% (!) of the pre-as-
phyxia level [27]. Finally in rats, brain ischemia significantly inhibited C-I dependent mito-
chondrial respiration, but when the same mitochondria were tested on succinate, no difference
from control values was detected [28]. Importantly, succinate supports the highest rate of ROS
generation in brain mitochondria [19, 29]. Indeed, we demonstrate a dramatic (4.5 folds) in-
crease in succinate-supported mitochondrial ROS generation in the in vitro environment,
mimicking reintroduction of O2 during reperfusion. In contrast, in the same organelles fueled
with glutamate-malate a considerable rise in ROS emission was achieved only when C-I was in-
hibited with rotenone or isoflurane. This suggests that unless C-I is inhibited, potential contri-
bution of NAD-linked respiration to ROS production is very modest compared to that of
FAD-linked respiration. Just recently, Chouchani et al demonstrated that in the heart, brain
and other organs the level of mitochondrial succinate dramatically (3–20 folds) increased dur-
ing ischemia, and succinate-supported mitochondrial respiration was responsible for accelerat-
ed mitochondrial ROS generation during reperfusion [36]. Similarly to the earlier reports [25,
26], these authors also demonstrated a rapid (5 min) decrease of cerebral succinate to the pre-
ischemic level during reperfusion [36]. The latter suggests a return of mitochondrial preference
in substrate oxidation from succinate to NAD-linked substrates. This also suggests that in the
later stages of reperfusion, proposed strategy with inhibition of C-I may become ineffective, as
inhibited C-I in the mitochondria oxidizing NAD-linked substrates may contribute to elevated
mitochondrial ROS emission. This may explain a loss of neuroprotection with delayed or pro-
longed use of isoflurane in this study. Thus, in neonatal HI-mice temporal therapeutic window
of isoflurane post-treatment is restricted to the onset and very early (initial 15 minutes) stage
of reperfusion which supports metabolic link of isoflurane neuroprotection to a post-ischemic
mitochondrial preference of succinate oxidation.
The loss of neuroprotection with an extention of isoflurane anesthesia from 15 minutes to
30 minutes was unexpected finding, and this result is very intriguing. In spontaneously respir-
ing mice the absence of protection with prolonged isoflurane post-treatment can be explained
by the inhibiting effect of isoflurane on CBF recovery which limits normalization of cerebral
O2 content. These data are consonant with reports that Isoflurane anesthesia alters autoregula-
tion of regional and global cerebral blood flows [30, 31]. When post-HI isoflurane anesthesia
Isoflurane, Mitochondria and Hypoxia-Ischemia
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was supported with MV, the recovery of CBF has improved. This significantly augmented the
neuroprotective effect of isoflurane in mice exposed to isoflurane for 15 minutes, and decreased
infarct volume in mice anesthetized for 30 minutes. However, only mice exposed to isoflurane
for 15 minutes of the initial reperfusion demonstrated significantly reduced infarct volume
compared to vehicle-treated animals. MV and isoflurane exposure for 30 minutes resulted in a
strong tendency (p = 0.08) toward neuroprotection compared to spontaneously respiring vehi-
cle treated animals. Thus, the use of MV is very important in experimental research of neuro-
protective properties of general anesthetics. It has been reported that isoflurane anesthesia, in
the dose similar to that used in our study, was lethal in spontaneously respiring p10 mice when
isoflurane was applied during HI-insult. The use of MV, however, significantly improved sur-
vival [14]. Importantly, even with the use of MV, isoflurane anesthesia exhibited a short thera-
peutic window, because extended (30 minutes) use of isoflurane with MV did not exert
neuroprotection. These data, at first glance, seem to be in a conflict with reports showing that a
prolongation of isoflurane pre-treatment from 4 to 25 minutes or an increase of the dose have
reduced the extent of HI brain injury in neonatal rats [32, 33]. However, in contrast to above
referenced reports, in our study we have used a post-treatment paradigm. Therefore, potential
mechanisms of anti-ischemic action of isoflurane used as the pre-conditioning differs from
that of the post-conditioning used here. It is also important to note, that anti-NMDA receptor
and GABA-type A receptor-stimulating action of isoflurane were proposed as neuroprotective
mechanisms in the pre- or intra-treatment settings, when the exposure to isoflurane was car-
ried-out prior- to or during oxygen-glucose deprivation [34, 35]. Our work does not contradict
to above referenced studies, but shows another mechanism when the anesthetic is used at the
initiation of reperfusion. This mechanism contributes to known mechanisms of isoflurane
neuroprotection,
In conclusion, as a post-treatment strategy, only brief isoflurane anesthesia initiated at the
onset of reperfusion significantly reduced brain injury, providing permanent neurological ben-
efit in neonatal HI-mice. The mechanism for this neuroprotection is related to deceleration of
mitochondrial ROS production during reperfusion and attenuation of oxidative injury. Howev-
er, temporal window of this therapeutic effect in neonatal mouse model of HI is short and re-
stricted to the initial reperfusion stage. Nevertheless, this finding does not cross out a
translational significance of our study, as in human neonates the timing of post-HI metabolic
shift favoring neuroprotective effect of isoflurane may differ from that in neonatal mice. There-
fore, further studies with the use of non-rodent animal models of HI should be focused on the
reperfusion timing when mitochondria—substrate interaction is optimal for neuroprotective
action of isoflurane.
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